Prelude Capital Management, LLC Thermo Fisher Scientific Inc. Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 349 shares of TMO stock, worth $189,266. This represents 0.01% of its overall portfolio holdings.

Number of Shares

349

Previous 349 -0.0%

Holding current value

$189,266

Previous $215,000 -0.0%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$531.86 - $624.21 $162,749 - $191,008	-306 Reduced 46.72%	349 $215,000
Q2 2024 Aug 14, 2024	BUY	$541.52 - $599.02 $69,856 - $77,273	129 Added 24.52%	655 $362,000
Q1 2024 May 15, 2024	BUY	$528.82 - $599.43 $278,159 - $315,300	526 New	526 $305,000
Q3 2023 Nov 14, 2023	BUY	$498.29 - $574.41 $692,623 - $798,429	1,390 Added 56.37%	3,856 $1.95 Million
Q2 2023 Aug 14, 2023	BUY	$508.46 - $591.13 $1.03 Million - $1.2 Million	2,034 Added 470.83%	2,466 $1.29 Million
Q1 2023 May 15, 2023	SELL	$535.0 - $604.82 $20,865 - $23,587	-39 Reduced 8.28%	432 $248,000
Q4 2022 Feb 14, 2023	SELL	$484.71 - $571.37 $342,689 - $403,958	-707 Reduced 60.02%	471 $259,000
Q3 2022 Nov 14, 2022	BUY	$507.19 - $604.49 $118,175 - $140,846	233 Added 24.66%	1,178 $597,000
Q2 2022 Aug 15, 2022	SELL	$500.9 - $612.21 $1.53 Million - $1.87 Million	-3,047 Reduced 76.33%	945 $513,000
Q1 2022 May 16, 2022	BUY	$524.0 - $644.92 $2.09 Million - $2.57 Million	3,992 New	3,992 $2.36 Million
Q4 2021 Feb 14, 2022	SELL	$569.0 - $667.24 $1.17 Million - $1.37 Million	-2,058 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$509.53 - $609.78 $356,161 - $426,236	699 Added 51.43%	2,058 $1.18 Million
Q2 2021 Aug 16, 2021	BUY	$441.0 - $508.24 $599,319 - $690,698	1,359 New	1,359 $686,000
Q4 2020 Feb 16, 2021	SELL	$435.06 - $527.66 $208,393 - $252,749	-479 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$359.77 - $441.52 $172,329 - $211,488	479 New	479 $211,000
Q3 2019 Nov 14, 2019	SELL	$268.46 - $305.43 $81,343 - $92,545	-303 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$257.51 - $295.55 $1.03 Million - $1.18 Million	-4,004 Reduced 92.96%	303 $89,000
Q4 2018 Feb 14, 2019	BUY	$208.47 - $251.98 $897,880 - $1.09 Million	4,307 New	4,307 $964,000

Others Institutions Holding TMO

# of Institutions

2,833

Shares Held

331M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $212B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Thermo Fisher Scientific Inc. Transaction History